Bupivicaine
35 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
35
Total Reports
10
Deaths Reported
2860.0%
Death Rate
Active Ingredients
Bupivicaine
Administration Routes
UnknownOtherParenteralIntra-ArticularTopicalIntralesionalIntradermalSubcutaneous
Species Affected
Dog 22
Cat 13
Most Affected Breeds
Domestic Shorthair 7
Domestic Mediumhair 4
Maltese 3
Crossbred Canine/dog 3
Dog (unknown) 3
Shih Tzu 2
Cat (unknown) 2
Terrier - Yorkshire 2
Boxer (German Boxer) 1
Terrier - Boston 1
Most Reported Reactions
Death 6
Hyperphosphataemia 6
Elevated creatinine 5
Vomiting 5
Not eating 5
Other abnormal test result NOS 4
Seizure NOS 4
Elevated alanine aminotransferase (ALT) 4
Not drinking 4
Proteinuria 4
Elevated symmetrical dimethylarginine (SDMA) 4
Death by euthanasia 4
Outcome Breakdown
Recovered/Normal
12 (34.3%)
Ongoing
7 (20.0%)
Died
6 (17.1%)
Outcome Unknown
6 (17.1%)
Euthanized
4 (11.4%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.